Tori Rodriguez, MA, LPC, AHC

Contributing Writer https://www.endocrinologyadvisor.com

Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years. She holds a BS in psychology from Georgia State University and an MA in counseling psychology from the Georgia School of Professional Psychology. Tori has also managed a medical practice and was instrumental in developing Georgia’s multispecialty telemedicine program. Photograph courtesy of Brooklyn Brat Images.

All articles by Tori Rodriguez, MA, LPC, AHC

Cardiovascular and Metabolic Disorders

Cardiovascular Effects of Pre-Workout Caffeine and Energy Supplements

Tori Rodriguez, MA, LPC, AHC

September 9, 2022

Gregory M Marcus, MD, MAS, and Jeffrey J. Hsu, MD, PhD, discuss the effect of caffeine and energy supplements on risk for cardiovascular events.

Cardiovascular and Metabolic Disorders

Spotlight on Increasing Myocardial Infarction Disparities in Young Women

Tori Rodriguez, MA, LPC, AHC

August 30, 2022

Viola Vaccarino, MD, PhD, Yuan Lu, ScD, and Ersilia M. DeFilippis, MD, discuss increasing rates of myocardial infarction among young women.

Cardiovascular and Metabolic Disorders

Substantial Post-Roe Risks for Patients With Cardiovascular Disease

Tori Rodriguez, MA, LPC, AHC

August 26, 2022

Joseph M Truglio, MD, Ali N. Zaidi, MD, Monica V. Dragoman, MD, and Linda Cassar, DNP, RNC-OB, CNE, discuss the effect of the overturning of Roe v Wade on patients with CVD.

Cardiovascular and Metabolic Disorders

Exploring Cardiovascular Risk in Transgender Patients

Tori Rodriguez, MA, LPC, AHC

July 22, 2022

A look into increased cardiovascular risk in patients who are transgender and suggestions for how to improve their health care.

Cardiovascular and Metabolic Disorders

Exploring the Link Between Oral Health and Cardiovascular Disease

Tori Rodriguez, MA, LPC, AHC

June 10, 2022

Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.

General Medicine

Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections

Tori Rodriguez, MA, LPC, AHC

March 25, 2022

Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.

Senior African American woman speaking with her general practitioner via video call during the COVID-19 pandemic to avoid an in person appointment.

Cardiovascular and Metabolic Disorders

Sex-Based Disparities in Atherosclerotic Cardiovascular Disease Care

Tori Rodriguez, MA, LPC, AHC

February 11, 2022

Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.

General Endocrinology, News

Exploring the Relationship Between Muscle Mass and NAFLD

Tori Rodriguez, MA, LPC, AHC

January 14, 2022

The understudied relationship between muscle mass and nonalcoholic fatty liver disease is assessed, including expert opinions the topic.

The Denver City Council recently passed an ordinance to allow the nation’s first supervised injection site. The Colorado General Assembly must also render an approval. A bipartisan bill to allow the site narrowly failed in a Republican-controlled Senate in 2018, but party control will change in 2019, making its passage more likely.3 Meanwhile, cities including San Francisco and Philadelphia are moving forward with their own site plans, despite warnings from the US Justice Department. Whether in Denver, San Francisco, Philadelphia, or elsewhere, expect the first supervised injection site in the United States to open in the near future, and for a legal battle to follow.

General Endocrinology

Addressing Drug Use-Associated Infective Endocarditis

Tori Rodriguez, MA, LPC, AHC

January 10, 2022

In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.

General Medicine

Update on Medications for Opioid Use Disorder: Clinician Perspectives

Tori Rodriguez, MA, LPC, AHC

September 17, 2021

Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.

Next post in General Medicine